Overview AZD6140 Oral Contraceptive Interaction Study Status: Completed Trial end date: 2008-10-01 Target enrollment: Participant gender: Summary The purpose of this study is to examine the effect of co-administration of AZD6140 and Nordette® on the blood levels of certain female hormones. Phase: Phase 1 Details Lead Sponsor: AstraZenecaTreatments: Contraceptive AgentsContraceptives, OralEstradiolEstradiol 17 beta-cypionateEstradiol 3-benzoateEstradiol valerateEthinyl EstradiolEthinyl Estradiol-Norgestrel CombinationEthinyl estradiol, levonorgestrel drug combinationLevonorgestrelPolyestradiol phosphateTicagrelor